Clinical Trial: Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy

Brief Summary: This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.

Detailed Summary:
Sponsor: Hospital Universitario Virgen de la Arrixaca

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hospital Universitario Virgen de la Arrixaca

Dates:
Date Received: February 26, 2009
Date Started: January 2008
Date Completion: November 2008
Last Updated: February 26, 2009
Last Verified: February 2009